Arkeia Corporation made its name as an early supporter of Linux and is now a leading player in the
market for network backup solutions for companies.
Founded in 1996, the company offers software solutions for backing up data on networks in heterogeneous environments. Its products are quick, reliable and easy to use. Its client/server architecture, administration capacity and multiflow and multiplex technologies allow it to offer technology previously only available to big companies at an affordable price. Arkeia supports several hundred backup libraries and more than 30 combinations of operating systems and hardware. More than 100,000 users worldwide, including 4,000 clients, protect their data every day with Arkeia. Arkeia Corporation is based in Carlsbad, California. The company is also established in Europe with head offices in Paris. | |||
![]() | Eptica is an EADS group spin-off. This software company designs, publishes and markets
an innovative customer relationship management solution focused on two fundamental
business goals:
- to establish and provide live interactive customer service and support over the internet using email, chat and co-browsing. - to build closer relationships with clients based on in-depth knowledge of their habits, expectations and specific needs. The Eptica Enterprise Suite solution comprises three main product lines: Email Management, Live Interaction and Customer Behaviour Analysis. | ||
ExaPortect is the market leader in Core Security Event Management (CSEM): monitoring, interpreting
and reporting on the security of core business systems and the corporate information
they contain.
Following the merger with Solsolft, in October 2006, ExaProtect will be the only vendor to integrate security policy change management and security information & event management (SIEM), to provide real-time remediation. | |||
Opentrust (anciennement Idealx) is a leader in trust infrastructures for secure electronic
transactions. The company provides a comprehensive software solution that bridges
the gap from the traditional defensive peripheral security based system, to the
modern trust based technology infrastructure, or "ecosystem".
The company currently has over 70 deployed customers in a wide range of blue chip accounts from most industries with one million users located throughout the world. | |||
![]() | Established in 2004, idylis proposes an integrated offering of management software applications developed
in ASP aimed at very small and small companies: accounting, sales management,
tax reports, payroll, email routing, etc. Developed exclusively in ASP mode, its
software meets conventional demands - functional wealth and user friendliness
- but also modern requirements: team and remote work as well as data sharing.
idylis is the first French company to provide an equivalent to the NetSuite and
Salesforce packages in the US. | ||
Founded in July 2000, Mereo offers revenue management solutions. It provides its clients, mainly leading
European media companies (television, radio and bill-boards), with advice and
solutions to increase their profitability through advertising revenue optimisation
techniques. Mereo's offer combines latest-generation forecasting techniques (using
neural networks) with classic management tools opening up a vast variety of possible
applications in new markets: leisure, tourism, hotels. | |||
Miriad Technologies is a software publishing company that brings an innovative approach to decision
support for the monitoring, diagnostics and control of industrial processes. The
auto-adaptive software components developed by Miriad Technologies allow companies
to react to data-flows coming from their industrial processes in almost real time.
They analyse production data on the fly and can detect and anticipate problems
or identify factors having the greatest impact on system performance to allow
more efficient control. | |||
Formed in 1992, Reportive (formerly Artech S.A.) is a software publisher specialised in performance indicators
and automated management reporting tools. Reportive offers a global solution allowing
functional analysts to design, produce, distribute and implement a suite of management
tools, including management charts, reports etc., tailored to their business intelligence
requirements. Operating on a simple Microsoft™ Office platform, these tools can
be easily implemented by the customer's own staff. | |||
![]() | Created in 2003, Sparus Software designs, develops and markets an innovative software suite which enables enterprises
to deploy and manage mobile handheld devices over wireless networks (GPRS/Edge/3G
and WiFi) in a cost effective way, thereby reducing operating expenses. EveryWAN
Mobility Manager is an all-in-one, plug & play solution which provides the most
advanced functionalities for managing Windows Mobile™ and Windows CE™ mobile devices,
including over-the-air security and administration, communication management and
real-time remote end-user support.
| ||
TEMIS, leader in Text Mining, provides Text Analytics solutions to optimize information
processing, turning unstructured data into actionable knowledge for information
extraction and automatic classification. Luxid®, TEMIS's Information Intelligence
solution, plays a critical role in Corporations (Life Science-Publishing-Industry)
and Governments (Homeland Security), in environments where information processing
is complex due to the great volume of data, such as Competitive Intelligence,
Image and media crisis intelligence, Customer Sentiment Analysis, Scientific Intelligence,
IP Management or content publishing, and provides substantial productivity gains. | |||
Winwise specialises in IT work for websites and highly complex tasks for high-traffic sites. | |||
Founded in 2001 by Patrick Asty and Xavier Tardif, Denyall is a software securiting company specialising in web application security. The
company operates wolrdwide, including the United States, Europe, Asia and South
America thanks to its various type of products: rWeb, rFTP and sProxy.
| |||
Electronics
3D Plus SA is a Thalès spin-off. Its 3D packaging technologies enable stacking of hybrid
components (memory, microprocessors, etc.) in embedded electronic systems, optimising
space, improving performance and enhancing system robustness. | |||
Avertec operates in the Electronic Design Automation (EDA) market. Its two products,
underpinned by innovative technology resulting from 40 person-years of research,
offer clients a significant competitive advantage in terms of execution time and
performance, particularly for the verification of embedded memory and complex
systems. With the development of nanometric technologies and ultra-high density
integrated circuits, Avertec's crosstalk analysis tools are at the cutting edge
of current semi-conductor design issues. | |||
DiBcom, founded in June 2000, is a French semiconductor company based on a fabless (no
factory) model, that designs, produces and sells integrated circuits for receiving
Digital terrestrial TV in mobile and portable environments. DiBcom's technology,
which can be added to any type of terminal, allows perfect reception of a high
number of TV channels in all mobile situations, in moving vehicles, on laptop
PCs, TVs without a rooftop antenna, and soon on mobile phones. | |||
![]() | Direct Energie is a lajor player in ernergy marketing in France. It offering is designed specifically
for small business customers, crafstmen, merchants, independant professionals,
companies managing numerous sites and municipalities. | ||
Emulation and Verification Engineering SA was created in April 2000 by a team of EDA specialists, mainly from Meta Systems
(Mentor Graphics group). EVE has developed a revolutionary verification solution
for integrated circuits known as ZEBU. This platform reduces design time for the
complex integrated circuits frequently used in communications equipment and electronic
equipment in general.
| |||
![]() | Nemoptic was created in 1999 by a team of specialists from Matra LCD and the French National
Centre for Scientific Research (CNRS). The company develops, produces and markets
bistable nematic LCD technology (originally developed by the CNRS) for producers
of LCD monitors. | ||
Novaled is engaged in the research, development and marketing of organic light-emitting
diode (OLED) technologies. The company is a spin-off of IAPP at the Dresden University
and IPMS at the Fraunhofer Society's, founded in 2001 and started operations in
March 2003. Novaled experienced a rapid growth in developing and commercializing
its proprietary technology maturing into a world-class technology provider. Novaled
markets its advanced PIN OLED technology together with its proprietary OLED materials
to display makers and lighting companies preparing their entry into this promising
new field. The company has a strong IP position manifesting in more than 130 patents
granted and filed. | |||
Tronic's Micro Systems is a spin-off from CEA Leti. It designs, manufactures and markets high value-added
MEMS (microelectromechanical systems) for medical, telecom, aerospace/defence
and instrument applications. | |||
VACO Microtechnologies produces manual and automatic cleaning equipment for the microtechnology industry
(microelectronics, micro systems, optronics etc.). It is positioned as a manufacturer
of equipment for ultra-clean environments. | |||
Web-based services
Aduno is a new teleconferencing services provider with a European focus that designs,
develops and sells automated and reservationless multipoint audio and Web services
for putting people in touch. | |||
![]() | Glowria is France's leading provider of online DVD rental services offered on a subscription
basis. The company is also developing Video on Demand (VoD) services enabling
the company to sell titles for a few euros either to be viewed immediately as
streamed content or to be download for later enjoyment. | ||
![]() | Keljob began life as a metasearch engine for job offers that allows users to find a
good percentage of the job offers online in France with a single search. Keljob
also references company job offers through their websites as well as searching
job-boards directly. | ||
SplitGames, Europe's leading video game swapping community, offers an innovative service
with which gamers can update their games library frequently at low cost. Rather
than just a service, SplitGames is a community website on which not only games
are exchanged but also information, tips and recommandation. | |||
![]() | Founded in 2004 by Elie de Coignac and Benoît Durand, Splendia operates a hotel booking website and exclusive brand name which positions itself
in the"luxury and character hotels" segment. The company has a selection of more
than 1,750 hotels world-wide and close to 70 employees based throughout numerous
offices in Europe, Miami and Hong Kong.
| ||
Miyowa is a global company providing compelling instant messaging and presence enriched Mobile Web 2.0 technologies. | |||
Telecoms
Arialcom designs, develops and manufactures antennas for GSM and UMTS mobile base stations. | |||
Founded in 2001, Baracoda is a european-based technology company providing innovatire wireless solutions
for practical living. Baracoda is the market leader in the Bluetooth Auto-ID industry.
The company purchased the Com One brand of consumer electronics products in may
2005. | |||
Esmertec is one of the leading software companies in JavaTM technologies and solutions
for mass-market mobile multimedia phones and embedded devices. Esmertec designs
and markets Java Virtual Machines (JVMs) and J2ME enabling software for handsets
with limited computing and storage capacity. Esmertec sells its products to mobile
phone and consumer electronics manufacturers. Formed in 1999, Esmertec is a global
company based in Zurich with engineering, sales and customer support operations
in Switzerland, the UK, the US, Singapore, China and Korea. Esmertec is also represented
in Japan. | |||
Optogone SA is an ENST Bretagne - France Telecom spin-off. Optogone designs and manufactures
liquid crystal components for fibre optical networks. | |||
Life Sciences
![]() | Amsterdam Molecular Therapeutics BV (AMT) is a gene therapy company founded in 1998. AMT focuses on the development
of gene-based therapies for orphan metabolic and ocular diseases. AMT's long-term
gene expression technology is based on specific delivery of therapeutic genes
into target organs or tissues. Production of AAV-based gene therapy vector has
been optimized and AMT has developed and validated a unique, stable and scalable
GMP production platform. Its lead product, AMT-011, is in phase II for the fisrt
indication: treatment of lipoprotein lipase deficiency type I.
The company's Management, Supervisory and Scientific Advisory board bring together
an extensive know-how from both gene science as well as the biotech and pharmaceutical
worlds. | ||
Biospace Med SA was founded by Nobel Prize winner Georges Charpak to provide with innovative
imaging devices based on his discoveries in high-energy physics and particle detection.
Biospace Med has developed a patented X-ray particle detector, which led to an
X-ray imaging system that can simultaneously capture multi-planar, full- body
X-rays with large reductions in radiation. The company's lead product, EOS ultra-low
dose 2D/3D, allows full-body imaging of patients in a weight- bearing position.
An advanced workstation, designed to generate a 3D skeletal image from the two
planar images, has been developed. The company has corporate headquarters in Paris
and Atlanta with an office in Montreal.
| |||
| www.biospacemed.com | |||
Biovex Ltd. is a biotechnology company based in Oxford (UK). Formed in 1998, Biovex
is developing a new class of vaccines for the treatment of cancer and chronic
infectious diseases. The company has two proprietary vaccine platforms (OncoVEX
and ImmunoVEX) and a functional genomics platform (NeuroVEX), all based on genetic
manipulation of the herpes simplex virus (HSV). Several of Biovex's products have
generated promising results in cancer patients during clinical trials. The company
also has a number of service contracts. | |||
CircuLite CircuLite is developing a miniature blood pump, designed to be placed superficially
like a pacemaker, for the long-term treatment of chronic heart failure. The Synergy
Pocket Circulatory Assist device is designed to rest a failing heart by supplementing
its natural function. By providing long-term circulatory assist on a minimally
invasive platform, CircuLite's Synergy has the potential to transform the management
of chronic heart failure and improve the quality of life for millions of patients
and their families. More information on the successful implantation of the first
patient in a European feasibility trial, read the press release (August 8, 2007) | |||
7TM Pharma is a discovery and development biotech company with focus on new pharmaceutical
drugs targeting 7TM receptors - a large group of highly valuable drug targets.
A rich in-house pipeline includes several well advanced programs within the main
therapeutic focus area - metabolic disorder - as well as other programs within
inflammation, therapeutic angiogenesis and cardiovascular disease. May 19th 2006,
7TM Pharma has acquired CareX SA, a privately held French company based in Strasbourg.
All CareX current operations are relocated to 7TM Pharma. The acquisition of CareX
strengthens 7TM's position as one of the leading biotechs in the metabolic drug
discovery and development space. | |||
![]() | Cytheris is dedicated to the development of growth factors able to enhance, drive and
restore immune system functions. The company is particularly interested in a recombinant
human interleukin-7 for immune reconstitution of immuno-depressed patients. Cytheris
is expecting an important success for its main product which is currently clinically
tested in the USA. | ||
Diatos SA is an Institut Pasteur spin-off. The company's mission is to develop and produce
new therapies relying on two proprietary vector-based delivery technologies that
can be used individually or in combination. These technologies improve the delivery
of the drug to the target cell or even to its nucleus. Diatos intends to focus
on medical applications where a major need has been identified, particularly in
oncology. | |||
Fovea is a company focusing on the research, development and marketing of innovative
medicines for the treatment of retinal diseases such as macular degeneration,
pigmentary retinitis, diabetic retinopathy and macular oedema. These diseases
of the back of the eye affect a large number of patients (more than 50 million
people in North America and Europe). The company is backed by a network of internationally
respected scientists and clinicians. Developments are made by both internal research
and development, in some ophthalmological indications, of drugs already tested
for other therapeutic indications. Fovea's strategy is to leverage its privileged
access to cutting-edge science and its careful targeting of patient cohorts. | |||
![]() | METabolic EXplorer focuses on the development of new bioprocesses. The company develops and applies
cutting-edge biotechnology tools to identify the metabolic pathways of bacteria,
yeasts and plants in order to design new fermentation-based biosynthetic pathways
for the production of chemicals. METabolic EXplorer has unique knowledge and expertise
in fields ranging from metabolic pathway quantification and modelling to the design
and engineering of novel production hosts for industrial biosynthesis of key chemicals.
METabolic EXplorer conducts product development in-house and collaboratively with
selected partners. | ||
Mutabilis is a biopharmaceutical company specialised in antibacterial drugs. It was founded
in 2001 by Xavier Nassif, professor of microbiology at the Necker medical school
in Paris and head of Inserm's U-570 unit. The company seeks to create a new class
of anti-infective medicines by developing drugs that are not antibiotics but which
selectively target the bacterial pathogens as soon as they penetrate, multiply
and try to spread in the blood and extracellular fluids, without preventing the
proliferation of commensal bacteria in their natural locations, such as the skin
or gut. This approach offer new therapeutic possibilities, particularly in the
field of nosocomial diseases. | |||
Novagali Pharma is a French biopharmaceutical company, founded in 2000, that develops innovative
ophthalmological products using its proprietary cationic emulsion technology.
The company targets products that will allow ophthalmologists to deliver optimal
treatment for a range of eye problems including ocular dryness and retinal diseases. | |||
In 2007, the public company Orexo has acquired Biolipox, a private research company developing novel, effective
drugs for treating respiratory diseases and other inflammatory diseases, such
as asthma, chronic
obstructive pulmonary disease (COPD), rhinitis, pain and arthritis. By drawing on its knowledge in the inflammatory research area, particularly arachidonic acid metabolism, Biolipox has created a portfolio of potential blockbusters in these therapeutic areas. Orexo is a pharmaceutical company which focuses on identifying suboptimal therapeutic characteristics of existing products and developing more efficient and effective delivery methods for them. | |||
![]() | Pangenetics B.V. is an antibody development company headquartered in the Netherland that also
maintains an office in England. It takes antibodies from the late research phase
through to clinical proof of concept. The company employs a lean business model
with most develpoment activities aoutsourced. Its most advanced candidate is a
CD40 antagonist that has already shown encouraging results in an open label phase
Ib/IIa Chrons study. | ||
Picometrics is developing proprietary technology (laser-induced fluorescence detection)
in the field of analytical laboratory instrumentation. The technology has much
greater sensitivity than competing molecular detection processes. | |||
![]() | The mission of SuperSonic Imagine is to develop a revolutionary technological platform for the measurement and
imaging of tissue eslasticity. The diagnosis performed using this ultrasound-based
technology is designed to provide a more efficient detection tool for both palpable
and non-palpable cancer lesions, improve diagnostic accuracy for improved assesment
of lesions and offer a new solution in the high growth segment of non-invasive
High Intensity Focused Ultrasound (HIFU) therapy. | ||
Xention Discovery Ltd is a drug discovery company that utilizes proprietary technologies to accelerate
the development of novel ion channel drugs, overcoming existing limitations in
ion channel drug discovery. The Company uses true electrophysiological data and
ion channel chemoinformatics to support medicinal chemistry and allow the development
of drugs that are potent and selective and have preferred functional properties.
Xention, which was founded in 2002, is a leader in ion channel drug discovery
and has a number of programs in the cardiovascular, neurological and metabolic
disease areas. | |||


































